Viewing Study NCT07238712

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2026-03-20 @ 3:23 AM
Study NCT ID: NCT07238712
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2025-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor
Sponsor: St. Petersburg State Pavlov Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia (AML) View
None Chronic Myeloid Leukemia View
None Myelodysplastic Syndromes (MDS) View
None Myeloprolipherative Neoplsm View
None Atypical Chronic Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Post-transplantation cyclophosphamide View
None Post-transplantation bendamustine View
None graft-versus-host disease View
None abatacept View
None ruxolitinib View